המנגיול - Hemangiol
×××ר××
×צפ××× ×××××¢ ××ר×× ×ר×פ××× ×ש ××××× ×¡ ××ש××× ×. ×× ××× × ×¨×©×× ××× ×¡ ××רש×× ×ר×פ××× ××× ×©× ×קצ××¢×ת רפ×××××.
× ×ª×× × ×ª×¨×פ×
×××¨×©× 
| ק×××¦× ×¤×¨×ק×××××ת (ATC4) | C07AA Beta blocking agents, non-selective | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ×ר××× ×¤×¢×× (ATC5) | Â
| ||||||||||||||||||
| צ×רת ××ª× | פ××× - PER OS | ||||||||||||||||||
| צ×רת ××× ×× | ת××ס×, SOLUTION ××× ×עת ××× ×× ×תר ×× ×רע×× ×ש ××××× ×ת ×תר××¤× ××ת×× ×××× ×× ××××××¥ ××¤× ×©××פ××¢ ××¢××× ×צר×× | ||||||||||||||||||
| ×ת×××× | For the treatment of proliferating infantile haemangioma requiring systemic therapy:⢠Life- or function-threatening haemangioma,⢠Ulcerated haemangioma with pain and/or lack of response to simple wound care measures,⢠Haemangioma with a risk of permanent scars or disfigurement.It is to be initiated in infants aged 5 weeks to 5 months | ||||||||||||||||||
| |||||||||||||||||||
| ×¢××× ×ר××¤× ××××ר×ת ××¢××× |
  | ||||||||||||||||||
| ער××× ××××ק×רפ××× | ער××× ×§×©×ר×× ××××ק×רפ××× |
|---|---|
| ××× ×××× ××××ר ××©×¨× ××ר×××ת |
| ××פ×ש ×××ר×× | ×××ר×× ×-PubMed |
|---|---|
| ××××¢ ×רשת | RxList WebMD Drugs.com |
| ×©× ××¦×¨× | PIERRE FABRE MEDICAMENT PRODUCTION, FRANCE |
| ×©× ××¢× ×ר×ש×× | PERRIGO ISRAEL AGENCIES LTD, ISRAEL |
| ר×ש××× | ת×ר×× ××ש×: 6/2017. ר×ש××× ×ת×ר××: |
| ת×ר×× ×¢×××× ××ר×× | {{{ת×ר×× ×¢××××}}} |
ת××× ×ª ×ר×××
השינוי האחרון נעשה בֹ־1 באוגוסט 2023 ב־05:47